Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity - EP3284520

The patent EP3284520 was granted to Shionogi on Jun 5, 2019. The application was originally filed on Apr 28, 2006 under application number EP17195280A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3284520

SHIONOGI
Application Number
EP17195280A
Filing Date
Apr 28, 2006
Status
Opposition Rejected
Feb 11, 2022
Grant Date
Jun 5, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GILEAD SCIENCESFeb 4, 2020ADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONJP2003032772
DESCRIPTIONJPH02108668
DESCRIPTIONJPH02108683
DESCRIPTIONJPH0296506
DESCRIPTIONUS2004133029
DESCRIPTIONWO0212173
DESCRIPTIONWO03016275
DESCRIPTIONWO03035076
DESCRIPTIONWO2004004657
DESCRIPTIONWO2004024693
DESCRIPTIONWO2005016927
OPPOSITIONJP2005312076
OPPOSITIONWO2005016927
OPPOSITIONWO2005092099
SEARCHEP1544199
SEARCHUS2005054645
SEARCHWO2004058757

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- JARMY, G. et al., J. Medical Virology, (20010000), vol. 64, pages 223 - 231-
DESCRIPTION- P. BESSE, Tetrahedron Asymmetry, (19990000), vol. 10, pages 2213 - 2224-
DESCRIPTION- RUSSELL A. BARROW, J. Am. Chem. Soc., (19950000), vol. 117, pages 2479 - 2490-
OPPOSITION- Barreca, Et Al., "Pharmacophore-Based Design of HIV-1 Intergrase Strand-Transfer Inhibitors", J. Med. Chem., (20050101), vol. 48, no. 22, pages 7084 - 7088, XP055539110-
OPPOSITION- BARRECA M L, ET AL, "Efficient 3D database screening for novel HIV-1 in inhibitors", JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES., AMERICAN CHEMICAL SOCIETY, COLOMBUS,OHIO., US, US, (20040701), vol. 44, no. 4, doi:10.1021/ci034296e, ISSN 0095-2338, pages 1450 - 1455, XP002558279
OPPOSITION- POMMIER YVES ET AL, "Integrase inhibitors to treat HIV/AIDS.", Nature Reviews. Drug Discovery, Nature Publishing Group, GB, GB, (20050301), vol. 4, no. 3, doi:10.1038/nrd1660, ISSN 1474-1784, pages 236 - 248, XP002364769
OPPOSITION- HAZUDA D J ET AL, "Inhibitors of strand transfer that prevent integration and inhibit HIV - 1 replication in cells.", Science, American Association for the Advancement of Science, US, US, (20000128), vol. 287, doi:10.1126/science.287.5453.646, ISSN 0036-8075, pages 646 - 650, XP002175834

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents